Company: CGCT
Filing Date: 2025-03-05
Form Type: S-1/A
Source: 0001104659-25-020969
Chunk: 136

Company: Cartesian Growth Corp III
Filing Date: 2025-03-05
Form: S-1/A
Chunk 136
---
 we give proper notice of
such redemption to the warrants holders and provided certain other conditions are met. We will not redeem the warrants as described above
unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise
of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the
measurement period. If and when the warrants become redeemable by us, we may not exercise our redemption right if the issuance of ordinary
shares upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or we are
unable to effect such registration or qualification. We will use our best efforts to register or qualify such ordinary shares under the
blue sky laws of the state of residence in those states in which the warrants were offered by us in this offering. Redemption of the
outstanding warrants could force you to (i) exercise your warrants and pay the exercise price therefor at a time when it may be
disadvantageous for you to do so, (ii) sell your warrants at the then-current market price when you might otherwise wish to hold
your warrants or (iii) accept the nominal redemption price which, at the time the outstanding warrants are called for redemption,
is likely to be substantially less than the market value of your warrants.

Our warrants may have an adverse effect on the market price of our Class A ordinary shares and make it more difficult to effectuate our initial business combination.

We will be issuing warrants to purchase 10,000,000
of our Class A ordinary shares (or up to 11,500,000 Class A ordinary shares if the underwriters’ over-allotment option
is exercised in full) as part of the units offered by this prospectus and, simultaneously with the closing of this offering, we will
be issuing in a private placement an aggregate of 6,000,000 private placement warrants, at $1.00 per private placement warrant. If the
private placement warrants become exercisable on a cashless basis, the exercise of such warrants may result in material dilution to our
public shareholders. In addition, if our sponsor or an affiliate of our sponsor or certain of our officers and directors make any working
capital loans, such persons may convert those loans into up to an aggregate of 1,500,000 private placement-equivalent warrants, at the
price of $1.00 per warrant, which conversion may result in material dilution to our public shareholders. To